
Home » Cadila Receives U.S. FDA Warning for Manufacturing Violations
Cadila Receives U.S. FDA Warning for Manufacturing Violations
July 8, 2011
The Ahmedabad-based pharmaceutical company Zydus Cadila said it had received a warning letter from the FDA over violations of current good manufacturing practices or cGMP regulations for finished pharmaceuticals at its Moraiya facility near Ahmedabad, reports said.
RTTNews
RTTNews
Upcoming Events
-
10Mar
-
16Mar
-
18Mar
-
23Mar
-
30Mar
-
06Apr